Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: A retrospective and prospective effectiveness study

Child: Care, Health and Development

Volumn 32, Issue 5, 2006, Pages 575-583

  Santosh, P J ^a   Baird, G ^a   Pityaratstian, N ^a   Tavare, E ^a   Gringras, Paul ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

ADHD; Autism; Stimulant medication

Indexed keywords

DEXAMPHETAMINE; METHYLPHENIDATE;

ABDOMINAL PAIN; AGGRESSION; AGITATION; ANOREXIA; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; AUTISM; BLEEDING; BODY WEIGHT DISORDER; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG INDUCED HEADACHE; DYSPHORIA; EXPLORATORY RESEARCH; FEMALE; FEVER; HALLUCINATION; HUMAN; HYPERACTIVITY; HYPOMANIA; IMPULSIVENESS; LETHARGY; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUESTIONNAIRE; RESTLESSNESS; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; STATISTICAL SIGNIFICANCE; STIMULUS RESPONSE; STUDENT T TEST; TACHYCARDIA; TASTE DISORDER; THROMBOCYTOPENIA; TIC; WEIGHT REDUCTION;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGGRESSION; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; METHYLPHENIDATE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33747062688     PISSN: 03051862     EISSN: 13652214     Source Type: Journal    
DOI: 10.1111/j.1365-2214.2006.00631.x     Document Type: Article

References (15)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, 4th Edn Test Revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, USA.
2. Barkley, R. A., McMurray, M. B., Edelbrock, C. S. & Robbins, K. (1990) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systematic placebo-controlled evaluation. Pediatrics, 86, 184-192.
3. Bech, P., Malt, U. F., Dencker, S. J., Ahlford, U. G., Elgen, K., Lewander, T., Londell, A., Simpson, G. M. & Lingjaerde, O. (1993) Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatrica Scandinavica, 87 (Suppl. 372).
4. Bishop, D. V. M. & Baird, G. (2001) Parent and teacher report of pragmatic aspects of communication: Use of the children's communication checklist in a clinical setting. Developmental Medicine and Child Neurology, 43, 809-818.
5. Clark, T., Feehan, C., Tinline, C. & Vostanis, P. (1999) Autistic symptoms in children with attention deficit-hyperactivity disorder. European Child and Adolescent Psychiatry, 8, 55.
6. Geurts, H. M., Verte, S., Oosterlaan, J., Roeyers, H., Hartman, C. A., Mulder, E. J., Berckelaer-Onnes, I. A. & Sergeant, J. A. (2004) Can the children's communication checklist differentiate between children with autism, children with ADHD, and normal controls? Journal of Child Psychology and Psychiatry and Allied Disciplines, 45, 1437-1453.
7. Ghaziuddin, M., Weidmer-Mikhail, E. & Ghaziuddin, N. (1998) Comorbidity of Aperger Syndrome: A preliminary report. Journal of Intellectual Disability Research, 42, 279-283.
8. Goldstein, S. & Schwebach, A. J. (2004) The comorbidity of pervasive developmental disorder and attention deficit hyperactivity disorder: results of a retrospective chart review. Journal of Autism and Developmental Disorders, 34, 329-339.
9. Goodman, R., Ford, T., Simmons, H., Gatward, R. & Meltzer, H. (2003) Using the strengths and difficulties questionnaire (SDQ) to screen for child psychiatric disorders in a community sample. European Child and Adolescent Psychiatry, 12, 9-14.
10. Gringras, P., Santosh, P. & Baird, G. (2006) Development of an Internet-based real-time system for monitoring pharmacological interventions in children with neurodevelopmental and neuropsychiatric disorders. Child: Care, health and develpment, 32, 591-600.
11. Guy, W. (1976) Early Clinical Drug Evaluation Unit (ECDEU) Assessment Manual for Psychopharmacology, revised. NIHM publication DHEW publication NO (Adm) 76-338. National Institute of Mental Health, Bethesda, MD, USA, pp. 217-222.
12. Lord, C., Rutter, M. & Lecouteur, A. (1994) Autism diagnostic interview-revised -a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659-685.
13. Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickle, A. & Rutter, M. (2000) The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205-223.
14. Quintana H., Birmaher B. & Stedge D., Lennon, S., Freed, J., Bridge, J. & Greenhill, L. (1995) Use of methylphenidate in the treatment of children with autistic disorder. Journal of Autism and Developmental Disorders, 25, 283-294.
15. Research Units on Paediatric Psychopharmacology (RUPP) Autism Network (2005) Randomised, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry, 62, 1266-1274.